Related Experiment Video
Updated: Jun 20, 2026
11:03
Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
The molecular links between TDP-43 dysfunction and neurodegeneration
Emanuele Buratti1, Francisco E Baralle1
1International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.
Advances in Genetics
|September 10, 2009
Summary
TDP-43 protein changes are central to neurodegenerative diseases like ALS. Understanding these biochemical alterations in TDP-43 is key to developing new therapies for these devastating conditions.
Area of Science:
- Neurodegenerative diseases
- Cellular metabolism
- Protein biochemistry
Background:
- TDP-43 protein is implicated in frontotemporal lobar degeneration with ubiquitin bodies (FTLD-U) and amyotrophic lateral sclerosis (ALS).
- Aberrant cytoplasmic localization, aggregation, and post-translational modifications of TDP-43 occur in affected neuronal tissues.
Purpose of the Study:
- To review biochemical and functional changes transforming wild-type TDP-43 into its pathological form.
- To examine potential pathological mechanisms of TDP-43 in gain- and loss-of-function scenarios.
Main Methods:
- Review of recent biochemical and molecular studies.
- Analysis of data from existing animal models.
- Examination of TDP-43 mutations associated with disease.
Main Results:
- TDP-43 undergoes aberrant localization, aggregation, degradation, ubiquitination, and phosphorylation in neurodegenerative diseases.
- Mutations and animal models strengthen the link between TDP-43 and disease pathogenesis.
Conclusions:
- Understanding TDP-43 modifications is crucial for defining its role in disease.
- Knowledge gained may lead to innovative therapeutic strategies for TDP-43-related neurodegenerative diseases.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...